Literature DB >> 20175288

Possible indications of beta-blockers in the perioperative period other than prevention of cardiac ischemia.

Yuji Kadoi1, Shigeru Saito.   

Abstract

According to the guidelines of the American College of Cardiology/American Heart Association 2006 for perioperative cardiovascular evaluation for non-cardiac surgery, beta-blocker therapy should be considered for high-risk individuals undergoing vascular surgery or high- and intermediate-risk patients undergoing non-cardiac surgery. This guideline might induce physicians to increasingly use beta-blockers in the hope of preventing perioperative cardiac complications. However, beta-blockers have potential beneficial effects outside the prevention of cardiac events. In addition to reducing anesthetic and analgesic requirements during the perioperative period, beta-blockers have neuroprotective effects in patients with brain trauma and possible effectiveness in the management of intraoperative awareness-induced post-traumatic stress disorder. Moreover, intrathecal administration of beta-blockers may have antinociceptive effects. Physicians need to bear in mind the benefits of beta-blockers for purposes other than preventing cardiac events when applied in the perioperative period, and they should be familiar with the pharmacodynamics and risk-benefit ratio with their use. This review focuses on possible extracardiac indications of beta-blockers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20175288     DOI: 10.1007/s00540-009-0865-x

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  136 in total

1.  Cardiovascular effects of forces applied during laryngoscopy. The importance of tracheal intubation.

Authors:  M J Bucx; R T van Geel; P A Scheck; T Stijnen
Journal:  Anaesthesia       Date:  1992-12       Impact factor: 6.955

2.  The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia.

Authors:  Yutaka Oda; Kiyonobu Nishikawa; Ichiro Hase; Akira Asada
Journal:  Anesth Analg       Date:  2005-03       Impact factor: 5.108

3.  Assessment of the efficacy of esmolol on the haemodynamic changes induced by laryngoscopy and tracheal intubation: a meta-analysis.

Authors:  E Figueredo; E M Garcia-Fuentes
Journal:  Acta Anaesthesiol Scand       Date:  2001-09       Impact factor: 2.105

Review 4.  [New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].

Authors:  Yasushi Mio
Journal:  Masui       Date:  2006-07

5.  Intrathecal landiolol inhibits nociception and spinal c-Fos expression in the mouse formalin test.

Authors:  Hang Zhao; Takeshi Sugawara; Shihiro Miura; Tetsuya Iijima; Satoshi Kashimoto
Journal:  Can J Anaesth       Date:  2007-03       Impact factor: 5.063

6.  Noradrenaline increases hyperalgesia to heat in skin sensitized by capsaicin.

Authors:  P D Drummond
Journal:  Pain       Date:  1995-03       Impact factor: 6.961

7.  Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.

Authors:  Ryosuke Nishio; Tetsuo Shioi; Shigetake Sasayama; Akira Matsumori
Journal:  J Am Coll Cardiol       Date:  2003-01-15       Impact factor: 24.094

8.  Myocardial ischemia during non-cardiac surgical procedures in patients with coronary-artery disease.

Authors:  W L Roy; G Edelist; B Gilbert
Journal:  Anesthesiology       Date:  1979-11       Impact factor: 7.892

9.  Exaggerated anesthetic requirements in the preferentially anesthetized brain.

Authors:  J F Antognini; K Schwartz
Journal:  Anesthesiology       Date:  1993-12       Impact factor: 7.892

10.  Esmolol bolus and infusion attenuates increases in blood pressure and heart rate during electroconvulsive therapy.

Authors:  A L Kovac; H Goto; K Arakawa; M P Pardo
Journal:  Can J Anaesth       Date:  1990-01       Impact factor: 5.063

View more
  6 in total

Review 1.  Beta-blockers in vascular surgery patients: is the debate still going on?

Authors:  George Galyfos; Konstantinos Filis; Fragiska Sigala; Georgios Geropapas
Journal:  J Anesth       Date:  2016-08-12       Impact factor: 2.078

2.  Esmolol modulates inhibitory neurotransmission in the substantia gelatinosa of the spinal trigeminal nucleus of the rat.

Authors:  Yutaka Yasui; Eiji Masaki; Fusao Kato
Journal:  BMC Anesthesiol       Date:  2011-09-05       Impact factor: 2.217

3.  The effect of esmolol compared to opioids on postoperative nausea and vomiting, postanesthesia care unit discharge time, and analgesia in noncardiac surgery: A meta-analysis.

Authors:  Venkatesan Thiruvenkatarajan; Richard Watts; Marni Calvert; Graeme Newcombe; Roelof Markus Van Wijk
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2017 Apr-Jun

Review 4.  The effect of perioperative esmolol on early postoperative pain: A systematic review and meta-analysis.

Authors:  Richard Watts; Venkatesan Thiruvenkatarajan; Marni Calvert; Graeme Newcombe; Roelof M van Wijk
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2017 Jan-Mar

5.  Do β-adrenoreceptor blocking drugs associate with reduced risk of symptomatic osteoarthritis and total joint replacement in the general population? A primary care-based, prospective cohort study using the Clinical Practice Research Datalink.

Authors:  Georgina Nakafero; Matthew Grainge; Ana Valdes; Nick Townsend; Christian Mallen; Weiya Zhang; Michael Doherty; Mamas A Mamas; Abhishek Abhishek
Journal:  BMJ Open       Date:  2019-08-01       Impact factor: 2.692

Review 6.  Neuroprotection against stroke and encephalopathy after cardiac surgery.

Authors:  Daniel G Jovin; Karl G Katlaps; Ben K Ellis; Benita Dharmaraj
Journal:  Interv Med Appl Sci       Date:  2019-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.